Skip to main content
. 2021 Nov 19;16(11):e0259940. doi: 10.1371/journal.pone.0259940

Table 5. Univariate and multivariate analysis of clinicopathological factors associated with overall survival post-hepatectomy.

Variables 5-year OS rate (%) Univariate P-value Multivariate analysis
HR (95% CI) P-value
< Metastatic tumor characteristics >
    Age (<65 years / ≥65 years) 64.2 / 59.8 0.968
    Sex (men/women) 64.2 / 56.3 0.698
    Tumor maximum size (<5 cm / ≥5 cm) 65.3 / 50.0 0.089
    Tumor number (<4 cm / ≥4 cm) 66.4 / 52.8 0.269
    H-stage (H1/H2, 3) 72.7 / 44.4 0.020 0.36 (0.11–1.89) 0.291
    Grade (A/B,C) 77.5 / 46.2 0.012 0.34 (0.08–1.39) 0.148
    Metastasis period (synch/meta) 52.3 / 74.5 0.124
    Pre-operative chemotherapy (-: +) 60.2 / 100 0.307
    Post-operative chemotherapy (-: +) 71.1 / 59.0 0.586
    Nomogram preoperative score (<11 / ≥11) 81.8 / 49.3 0.020 0.50 (0.12–1.96) 0.292
    PD-1 (-: +) 53.2 / 87.7 0.023 0.19 (0.03–1.10) 0.032
    PD-L1 (-: +) 42.3 / 82.3 0.007 0.64 (0.23–1.77) 0.382
    IDO (-: +) 43.5 / 80.7 0.007 0.37 (0.13–1.04) 0.049
    TAMs (-: +) 48.0 / 82.6 0.005 0.66 (0.18–2.39) 0.520
        cTAMs (-: +) 58.2 / 76.6 0.821
        mTAMs (-: +) 52.0 / 79.9 0.031 0.77 (0.21–2.85) 0.701
< Primary tumor characteristics >
    Colon / rectum 67.1 / 59.8 0.910
    Tumor differentiation (diff./ undiff.) 64.3 / 25.0 <0.001 0.02 (0.002–0.20) <0.001
    T (2,3/4) 74.4 / 35.2 0.040 0.62 (0.23–1.72) 0.470
    Lymph node metastasis (-: +) 75.6 / 83.9 0.442
    Lymphatic invasion (-: +) 74.1 / 62.1 0.761
    Venous invasion (-: +) 78.5 / 58.3 0.515

synch/ meta: synchronous/ metachronous, diff./undiff.: differentiated histological type/undifferentiated histological type.